Scarica l'app Stockscreener
11.38
3.40%
-0.40
Dopo l'orario di chiusura:
11.38
Precedente Chiudi:
$11.78
Aprire:
$11.9
Volume 24 ore:
2.05M
Relative Volume:
1.11
Capitalizzazione di mercato:
$638.82M
Reddito:
$27.46M
Utile/perdita netta:
$-46.05M
Rapporto P/E:
-8.8217
EPS:
-1.29
Flusso di cassa netto:
$-33.83M
1 W Prestazione:
+5.18%
1M Prestazione:
+56.75%
6M Prestazione:
+61.42%
1 anno Prestazione:
+34.52%
Intervallo 1D:
$11.26
$12.03
Intervallo di 1 settimana:
$10.36
$12.03
Portata 52W:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
Nome
Zevra Therapeutics Inc
Settore
Industria
Telefono
(321) 939-3416
Indirizzo
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Confronta ZVRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
11.38 | 588.86M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-08 | Ripresa | Cantor Fitzgerald | Overweight |
| 2024-10-07 | Iniziato | Guggenheim | Buy |
| 2024-09-24 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-09-24 | Reiterato | Maxim Group | Buy |
| 2024-04-02 | Reiterato | Maxim Group | Buy |
| 2024-03-12 | Iniziato | William Blair | Outperform |
| 2023-03-17 | Iniziato | Maxim Group | Buy |
Mostra tutto
Zevra Therapeutics Inc Borsa (ZVRA) Ultime notizie
Analyzing Zevra Therapeutics Inc. with risk reward ratio charts2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com
What the charts say about Zevra Therapeutics Inc. today2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a top dividend aristocrat candidate2025 Volatility Report & Expert Curated Trade Setups - newser.com
Zevra Therapeutics (ZVRA) Surges 12.3%: Is This an Indication of Further Gains? - Yahoo Finance
Should you wait for a breakout in Zevra Therapeutics Inc.July 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com
Will breakout in Zevra Therapeutics Inc. lead to full recoveryNew Guidance & Smart Investment Allocation Insights - newser.com
Why Zevra Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
How hedge fund analytics apply to Zevra Therapeutics Inc. stockWeekly Profit Analysis & High Return Stock Watch Alerts - newser.com
Is ZVRA Setting Up For Another Leg Higher? - RTTNews
Using economic indicators to assess Zevra Therapeutics Inc. potential2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock test record highs in 2025July 2025 WrapUp & Risk Adjusted Swing Trade Ideas - newser.com
Is this a good reentry point in Zevra Therapeutics Inc.Gold Moves & Growth Focused Stock Pick Reports - newser.com
Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap Down Following Insider Selling - MarketBeat
Zevra Therapeutics rises amid takeover speculation - MSN
What to do if you’re stuck in Zevra Therapeutics Inc.Market Trend Summary & Reliable Momentum Entry Alerts - newser.com
Insider Selling: Zevra Therapeutics (NASDAQ:ZVRA) CEO Sells 19,500 Shares of Stock - MarketBeat
Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call - 富途牛牛
Zevra Therapeutics, Inc. $ZVRA Position Cut by Janney Montgomery Scott LLC - MarketBeat
Zevra Therapeutics CEO Neil McFarlane sells $210k in shares By Investing.com - Investing.com Nigeria
Could Zevra Therapeutics’ (ZVRA) Insider Buying Hint at Greater Management Confidence in Growth Ahead? - Sahm
Zevra Therapeutics CEO Neil McFarlane sells $210k in shares - Investing.com India
Can Zevra Therapeutics Inc. (1GDA) stock sustain breakout momentumDip Buying & Stepwise Trade Signal Implementation - newser.com
How moving averages guide Zevra Therapeutics Inc. tradingJuly 2025 Summary & Stock Timing and Entry Methods - newser.com
Chart overlay techniques for tracking Zevra Therapeutics Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com
What moving averages say about Zevra Therapeutics Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Zevra Therapeutics (ZVRA): Evaluating Valuation Following Insider Buying and Sustained Revenue Growth - Yahoo
Zevra Therapeutics gains amid takeover speculation - MSN
Assessing Zevra Therapeutics (ZVRA) Valuation Following Strong Revenue Growth and Insider Buying - Sahm
Why global investors buy Zevra Therapeutics Inc. (1GDA) stock2025 Key Highlights & AI Enhanced Trading Signals - newser.com
Using RSI to spot recovery in Zevra Therapeutics Inc.Earnings Risk Report & Long-Term Investment Growth Plans - newser.com
What drives Zevra Therapeutics Inc stock priceBearish Engulfing Patterns & Breakout Portfolio Performance - earlytimes.in
What drives Zevra Therapeutics Inc 1GDA stock priceEx-Dividend Date Alerts & Affordable Market Growth - earlytimes.in
The Three-year Returns Have Been Decent for Zevra Therapeutics (NASDAQ:ZVRA) Shareholders Despite Underlying Losses Increasing - 富途牛牛
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
38,000-Share Inducement: Zevra Therapeutics Awards Options to Two New Hires, Vesting Over 4 Years - Stock Titan
Zevra Therapeutics (NASDAQ:ZVRA) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Zevra Therapeutics' Stock Soars on Strong Performance and Strategic Wins: What It Means for Investors - FinancialContent
Will Zevra Therapeutics Inc. rebound enough to break evenMarket Weekly Review & Weekly High Conviction Ideas - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock benefit from Fed rate cutsCPI Data & Community Consensus Stock Picks - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a buy for dividend portfoliosJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Zevra Therapeutics Inc Azioni (ZVRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):